Amy Hankin
Impact in
-
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 10
- Prostate Cancer Diagnosis and Treatment 3
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- PARP inhibition in cancer therapy 1
- Co-authors
- Michael J. Pishvaian (1 shared paper)John Lindsay Marshall (1 shared paper)Jimmy J. Hwang (1 shared paper)Rebecca S. Slack (1 shared paper)Aiwu Ruth He (1 shared paper)Jonathan Robert Brody (1 shared paper)Louis M. Weiner (1 shared paper)Wei Jiang (1 shared paper)
- Journals
- Annals of Oncology (6 papers)Journal for ImmunoTherapy of Cancer (3 papers)Frontiers in Oncology (1 paper)Cancer (1 paper)British Journal of Urology (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Amy Hankin
12 papers receiving 383 citations
Peers
Comparison fields: 5 of 36
- Oncology 236
- Pulmonary and Respiratory Medicine 175
- Immunology 84
- Cancer Research 35
- Molecular Biology 96
Countries citing papers authored by Amy Hankin
This map shows the geographic impact of Amy Hankin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Hankin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Hankin more than expected).
Fields of papers citing papers by Amy Hankin
This network shows the impact of papers produced by Amy Hankin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Hankin. The network helps show where Amy Hankin may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Hankin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 248 | |
| 2 | 2018 | 58 | |
| 3 | 2020 | 24 | |
| 4 | 2021 | 24 | |
| 5 | 2020 | 12 | |
| 6 | 2020 | 6 | |
| 7 | 2025 | 6 | |
| 8 | 2020 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2018 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 0 |
About Amy Hankin
Amy Hankin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Immunology and Hepatology, having authored 13 papers that have together received 385 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers), Immunotherapy and Immune Responses (3 papers), PARP inhibition in cancer therapy (1 paper), Genetic factors in colorectal cancer (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (236 citations), Pulmonary and Respiratory Medicine (175 citations), Immunology (84 citations), Cancer Research (35 citations) and Molecular Biology (96 citations). Amy Hankin has collaborated with scholars based in United States and India. Frequent co-authors include Michael J. Pishvaian, John Lindsay Marshall, Jimmy J. Hwang, Rebecca S. Slack, Aiwu Ruth He, Jonathan Robert Brody, Louis M. Weiner, Wei Jiang, Fatima H. Karzai and Marijo Bilušić. Their work appears in journals such as Annals of Oncology, Journal for ImmunoTherapy of Cancer, Frontiers in Oncology, Cancer and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.